Prognostic Significance of immune-associated Side Effects under Radioimmunotherapy and Immunotherapy alone in Patients of the prospective ST-ICI Study
Schweizer C, Schubert P, Haderlein M, Rutzner S, Semrau S, Donaubauer AJ, Becker I, Frey B, Fietkau R, Gaipl U, Hecht M (2020)
Publication Type: Conference contribution
Publication year: 2020
Journal
Publisher: SPRINGER HEIDELBERG
City/Town: HEIDELBERG
Pages Range: S182-S182
Conference Proceedings Title: STRAHLENTHERAPIE UND ONKOLOGIE
Event location: Weisbaden
Authors with CRIS profile
Marlen Haderlein
Department of Radiation Oncology
Sandra Rutzner
Department of Radiation Oncology
Sabine Semrau
Medizinische Fakultät
Anna-Jasmina Donaubauer
Department of Radiation Oncology
Ina Becker
Department of Radiation Oncology
Benjamin Frey
Department of Radiation Oncology
Rainer Fietkau
Lehrstuhl für Strahlentherapie
Udo Gaipl
Department of Radiation Oncology
Markus Hecht
Department of Radiation Oncology
How to cite
APA:
Schweizer, C., Schubert, P., Haderlein, M., Rutzner, S., Semrau, S., Donaubauer, A.-J.,... Hecht, M. (2020). Prognostic Significance of immune-associated Side Effects under Radioimmunotherapy and Immunotherapy alone in Patients of the prospective ST-ICI Study. In STRAHLENTHERAPIE UND ONKOLOGIE (pp. S182-S182). Weisbaden, DE: HEIDELBERG: SPRINGER HEIDELBERG.
MLA:
Schweizer, C., et al. "Prognostic Significance of immune-associated Side Effects under Radioimmunotherapy and Immunotherapy alone in Patients of the prospective ST-ICI Study." Proceedings of the 26th Annual Conference of the German-Society-for-Radiation-Oncology (DEGRO), Weisbaden HEIDELBERG: SPRINGER HEIDELBERG, 2020. S182-S182.
BibTeX: Download